CodeMap® Compliance Briefing: October 30, 2014
Earlier this year, Congress enacted the Protecting Access to Medicare Act of 2014 (PAMA), which will in the future profoundly affect how laboratories are reimbursed by the Medicare program. A primary goal of this legislation is to determine what private payers reimburse for laboratory procedures and subsequently set Medicare rates to match. The process will most likely be arduous and painful, but Congress hopes it will result in a more equitable clinical laboratory fee schedule. This past week, the Centers for Medicare and Medicaid Services (CMS) published an important notice via the Federal Register, which represents the first step in establishing market-based reimbursement rates for the Medicare program. This notice calls for nom....
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.